The pharmaceuticals drugs market in France is prepared to decline from $35.5 billion in 2017 to $34.16 billion in 2021, representing a negative compound annual rate of growth of 1%, according during the forecast period. Latest reports states that in spite of France’s strong public health insurance system and rising senior population, increasing pressure on →
Click here to submit Post PR News
French pharmaceutical market to stagnate as government holds generics to cut healthcare spending
The pharmaceuticals drugs market in France is prepared to decline from $35.5 billion in 2017 to $34.16 billion in 2021, representing a negative compound annual rate of growth of 1%, according during the forecast period. Latest reports states that in spite of France’s strong public health insurance system and rising senior population, increasing pressure on →
0 Views : 923
Glenmark’s consolidated revenue at Rs. 22,798.16 Mn. for Q4 FY 2017 – 18
Mumbai, India, May 29, 2018 Glenmark Pharmaceuticals Limited, a research-led global integrated pharmaceutical company, today announced its financial results for the fourth quarter and year ended March 31, 2018. For the fourth quarter ended March 31, 2018, Glenmark’s consolidated revenue →
0 Views : 792
Age-related macular degeneration market will rise to $11.5 billion by 2026
Pharmaceutical sales for age-related macular degeneration (AMD) marketplaces were projected to be $4.9 billion in 2016, and it’s expected to reach a price of $11.5 billion in 2026, with a Compound Annual Growth Rate (CAGR) rise of 8.9%, stated by →
0 Views : 865
BIOFACH INDIA together with INDIA ORGANIC 2017
11 November 2017 The ninth edition of BIOFACH INDIA together with INDIA ORGANIC 2017 concluded at India Expo Mart Limited (IEML), Greater Noida, Delhi-NCR on 11 November 2017 with a resounding success. The three-day exhibition witnessed an overwhelming response from →
0 Views : 777
The German pharmaceuticals market expected to grow to $86.3 billion in 2021
June 19, 2017 GlobalData, the industry analysis specialist, has released its latest report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Germany”. The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Germany. →
0 Views : 1282
Abengoa Bioenergia, S.A. – Biotechnology Company
Abengoa Bioenergia, S.A. (Abengoa Bioenergy), a subsidiary of Abengoa, S.A., is a biotechnology company that develops new technologies for the production of biofuels and chemical bioproducts. Abengoa Bioenergy specializes in the development of innovative technology solutions contributing to the sustainability →
0 Views : 1695
Abengoa Bioenergia, S.A. – Biotechnology Company
Abengoa Bioenergia, S.A. (Abengoa Bioenergy), a subsidiary of Abengoa, S.A., is a biotechnology company that develops new technologies for the production of biofuels and chemical bioproducts. Abengoa Bioenergy specializes in the development of innovative technology solutions contributing to the sustainability →
0 Views : 1853
Sun Pharma to acquire branded oncology product Odomzo® (sonidegib) for global markets
MUMBAI (INDIA) & PRINCETON NJ (USA) – 22 December 2016: Sun Pharma (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, Sun Pharmaceutical Industries Ltd and includes its subsidiaries or associate companies today announced its plans to acquire a branded →
0 Views : 1483
Dr. Reddy’s Laboratories announces the launch of Raloxifene HCl Tablets, USP in the U.S. Market
Hyderabad, India and Princeton, NJ, USA. 11 November 2016 – Dr. Reddy’s Laboratories Ltd (BSE: 500124, NSE: DRREDDY, NYSE: RDY) announced today that it has launched Raloxifene hydrochloride tablets in 60 mg, a therapeutic equivalent generic version of Evista® (raloxifene →
0 Views : 1318
Dr. Reddy’s Laboratories announces new strategic deal with Gland Pharma in the U.S. Market
Hyderabad, India and Princeton, NJ, USA. October 26, 2016— Dr. Reddy’s Laboratories Ltd (BSE: 500124, NSE: DRREDDY, NYSE: RDY) announced today that it has entered into a strategic collaboration with Gland Pharma, a globally recognized developer and manufacturer of sterile →
1 Views : 1153
